Document Detail


Factors affecting patency of subintimal infrainguinal angioplasty in patients with critical lower limb ischemia.
MedLine Citation:
PMID:  16968668     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Because subintimal angioplasty (SA) is a technique that can achieve recanalization of long arterial occlusions, it is considered an alternative to lower limb bypass operations. The aim of this prospective study was to identify the risk factors that affect patency of SA in patients suffering from critical limb ischemia (CLI). METHODS AND RESULTS: 51 consecutive infrainguinal SA were done in 46 patients suffered from CLI. The patients were followed-up with regular duplex scans up to 12 months post-intervention. Sex, atherosclerosis risk factors, and some technical details of the procedure (number of patent run-off vessels after the procedure, length and re-entry point of angioplasty) were examined as potential risk factors of patency, using survival analysis statistical techniques. The overall patency rate at 12 months post-intervention was 50%. According to Cox-regression analysis, the factors that affect patency were the number of run-off vessels and the length of occlusion. Patients with two or three run-off vessels had a hazard of occlusion of 0.30 (P = .027) compared to those who had one run-off vessel. The 12-months patency in patients with more than one run-off vessels was 81% vs. 25% in patients with one run-off vessel. Regarding the length of angioplasty, the hazard of reocclusion was 1.02 for every centimeter of occlusion (P = .049). CONCLUSIONS: The number of patent run-off crural vessels after the angioplasty and the length of occlusion are significant risk factors for reocclusion of infrainguinal SA in patients with CLI. Trying to recanalize more than one run-off vessels could raise the SA patency.
Authors:
A M Lazaris; C Salas; A C Tsiamis; P A Vlachou; A Bolia; G Fishwick; P R Bell
Related Documents :
2032278 - Multicenter evaluation of a new fixed-wire coronary angioplasty catheter system: clinic...
2966678 - Blood velocity measurements during selective coronary angiography before and after perc...
8752798 - Ten-year follow-up of percutaneous transluminal coronary angioplasty for proximal left ...
10149588 - Coronary interventions in ischemic heart disease.
15189518 - Is right ventricular outflow tract pacing an alternative to left ventricular/biventricu...
8460078 - Role of aldosterone in congestive heart failure.
Publication Detail:
Type:  Comparative Study; Journal Article     Date:  2006-09-11
Journal Detail:
Title:  European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery     Volume:  32     ISSN:  1078-5884     ISO Abbreviation:  Eur J Vasc Endovasc Surg     Publication Date:  2006 Dec 
Date Detail:
Created Date:  2006-11-10     Completed Date:  2007-01-11     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9512728     Medline TA:  Eur J Vasc Endovasc Surg     Country:  England    
Other Details:
Languages:  eng     Pagination:  668-74     Citation Subset:  IM    
Affiliation:
Attikon Teaching Hospital, 3rd Surgical Department, Athens, Greece. amlazaris@med.uoa.gr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Amputation
Angioplasty / methods*
Arterial Occlusive Diseases / mortality,  physiopathology,  surgery*
Female
Femoral Artery / surgery
Follow-Up Studies
Humans
Ischemia / mortality,  surgery*
Kaplan-Meiers Estimate
Limb Salvage
Lower Extremity / blood supply*
Male
Middle Aged
Popliteal Artery / surgery
Prospective Studies
Regression Analysis
Reoperation
Risk Factors
Time Factors
Treatment Outcome
Tunica Intima / surgery
Vascular Patency*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The occurrence of arterio-venous fistula during lower limb subintimal angioplasty: treatment and out...
Next Document:  Intranasal administration of adjuvant-combined recombinant influenza virus HA vaccine protects mice ...